{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","lowerLimit":"0.1","upperLimit":"395.0","value":"12.29"},{"groupId":"OG001","lowerLimit":"0.1","upperLimit":"247.0","value":"14.71"},{"groupId":"OG002","lowerLimit":"0.1","upperLimit":"150.1","value":"12.14"},{"groupId":"OG003","lowerLimit":"2.1","upperLimit":"269.1","value":"20.71"},{"groupId":"OG004","lowerLimit":"0.1","upperLimit":"258.1","value":"15.14"},{"groupId":"OG005","lowerLimit":"4.1","upperLimit":"246.3","value":"48.57"},{"groupId":"OG006","lowerLimit":"5.3","upperLimit":"213.1","value":"26.14"},{"groupId":"OG007","lowerLimit":"8.3","upperLimit":"46.7","value":"22.14"},{"groupId":"OG008","lowerLimit":"0.1","upperLimit":"84.4","value":"10.14"},{"groupId":"OG009","lowerLimit":"0.1","upperLimit":"127.9","value":"107.00"},{"groupId":"OG010","lowerLimit":"0.1","upperLimit":"81.3","value":"57.14"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"29"},{"groupId":"OG001","value":"90"},{"groupId":"OG002","value":"107"},{"groupId":"OG003","value":"50"},{"groupId":"OG004","value":"29"},{"groupId":"OG005","value":"16"},{"groupId":"OG006","value":"6"},{"groupId":"OG007","value":"5"},{"groupId":"OG008","value":"41"},{"groupId":"OG009","value":"18"},{"groupId":"OG010","value":"75"}],"units":"Participants"}],"description":"Time from the first dose of investigational product (IP) to the first documentation of PD or death from any cause, whichever occurs first Data will be collected and analyzed per Cohort Totals.","dispersionType":"Full Range","groups":[{"description":"CC220","id":"OG000","title":"Cohort A: Total"},{"description":"CC220 + DEX","id":"OG001","title":"Cohort B: Total"},{"description":"CC220","id":"OG002","title":"Cohort D: Total"},{"description":"CC220 + DARA + DEX","id":"OG003","title":"Cohort E: Total"},{"description":"CC220 + BORT + DEX","id":"OG004","title":"Cohort F: Total"},{"description":"CC220 + CFZ + DEX","id":"OG005","title":"Cohort G: Total"},{"description":"CC220 + DEX","id":"OG006","title":"Cohort H1"},{"description":"CC220 + DEX","id":"OG007","title":"Cohort H2"},{"description":"CC220 + DEX","id":"OG008","title":"Cohort I"},{"description":"CC220 + NE-ASCT","id":"OG009","title":"Cohort J: Total"},{"description":"CC220 + DARA + DEX","id":"OG010","title":"Cohort K"}],"paramType":"MEDIAN","populationDescription":"Safety Population - As per protocol, DOR and PFS will combine arms in the cohort for endpoint presentation","reportingStatus":"POSTED","timeFrame":"On Average of (Cohort A: 44.96, Cohort B: 32.79, Cohort D: 21.14, Cohort E: 53.74, Cohort F: 46.34, Cohort G: 63.26, Cohort H1: 58.10, Cohort H2: 22.11, Cohort I: 20.96, Cohort J: 86.21, Cohort K: 56.29) Weeks","title":"Progression Free Survival","type":"SECONDARY","unitOfMeasure":"Weeks"}